- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
24 result(s) found for: Opacity.
Displaying page 1 of 2.
EudraCT Number: 2011-000608-16 | Sponsor Protocol Number: 5466 | Start Date*: 2011-12-21 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust [...] | ||
Full Title: To evaluate the safety and effectiveness of human ex vivo expanded autologous limbal stem cells for the treatment of unilateral total limbal stem cell deficiency | ||
Medical condition: unilateral total limbal stem cell deficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002845-23 | Sponsor Protocol Number: CCD-GPLSCD01-03 | Start Date*: 2015-12-16 | |||||||||||
Sponsor Name:Holostem Terapie Avanzate s.r.l. | |||||||||||||
Full Title: Multinational, multicentre, prospective, open-label, uncontrolled clinical trial to assess the efficacy and safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoratio... | |||||||||||||
Medical condition: corneal lesions with associated moderate to severe limbal stem cell deficiency due to ocular burns | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) BE (Ongoing) NL (Ongoing) FR (Completed) PL (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003180-11 | Sponsor Protocol Number: 15070 | Start Date*: 2016-03-14 |
Sponsor Name:University of Nottingham | ||
Full Title: Management of active and established corneal neovascularisation to prevent visual impairment | ||
Medical condition: Corneal new vessels | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-001344-11 | Sponsor Protocol Number: CCD-GPLSCD01-03-FU | Start Date*: 2018-04-11 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: Multinational, multicenter, prospective, long-term safety and efficacy follow-up study after Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration of corneal epithelium i... | |||||||||||||
Medical condition: corneal lesions with associated moderate to severe limbal stem cell deficiency due to ocular burns | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PL (Completed) FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018919-16 | Sponsor Protocol Number: TG-MV-010 | Start Date*: 2010-06-28 | |||||||||||
Sponsor Name:ThromboGenics NV | |||||||||||||
Full Title: An Open-Label, Ascending- Exposure-Time, Single Center Trial to Evaluate the Pharmacokinetic Properties of Ocriplasmin (Generic Name of the Molecule Microplasmin) Intravitreal Injection in Subjects... | |||||||||||||
Medical condition: Patients who require primary pars plana vitrectomy. A sample of vitreous will be taken at beginning of surgery for PK analysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001622-29 | Sponsor Protocol Number: ALI-P01-21-006 | Start Date*: 2023-03-01 | |||||||||||
Sponsor Name:Alimera Sciences Europe Limited | |||||||||||||
Full Title: A NON-RANDOMISED, OPEN-LABEL, UNCONTROLLED, MULTI-CENTRE, PHASE IIIB STUDY EVALUATING THE SAFETY AND EFFICACY OF FLUOCINOLONE ACETONIDE 190 MICROGRAMS INTRAVITREAL IMPLANT IN PAEDIATRIC SUBJECTS FR... | |||||||||||||
Medical condition: Non-Infectious Uveitis affecting the posterior segment | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004891-31 | Sponsor Protocol Number: FFR110537 | Start Date*: 2016-08-03 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Two-Year Study to Evaluate the Ocular Safety of Once-Daily, Fluticasone Furoate Nasal Spray 110mcg in Adults and Adolesc... | ||
Medical condition: Rhinitis, Allergic, Perennial | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2009-015559-25 | Sponsor Protocol Number: KCH1724 | Start Date*: 2010-04-22 | |||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | |||||||||||||
Full Title: Preoperative intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: A randomized, double-masked, controlled study | |||||||||||||
Medical condition: Retinopathy is a well recognised complication of diabetes and is a leading cause of vision loss in this patient group. The severity of diabetic retinopathy varies, but in its most severe form (pro... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001841-23 | Sponsor Protocol Number: I.2016.010 | Start Date*: 2016-11-16 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A multicenter, randomized, open-label, two-arms phase I/II clinical trial to asses efficacy and safety of cord blood eye drops in neurotrophic keratopathy | |||||||||||||
Medical condition: Neurotrophic Keratitis, stage 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005881-17 | Sponsor Protocol Number: RIN-PF-303 | Start Date*: 2022-08-18 | |||||||||||
Sponsor Name:UNITED THERAPEUTICS CORPORATION | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON-2) | |||||||||||||
Medical condition: Idiopathic Pulmonary Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DK (Ongoing) IT (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003180-54 | Sponsor Protocol Number: 20275 | Start Date*: 2020-04-25 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090 | |||||||||||||
Medical condition: Retinopathy of prematurity | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Trial now transitioned) SE (Ongoing) GB (GB - no longer in EU/EEA) DE (Completed) AT (Prematurely Ended) HU (Completed) ES (Ongoing) NL (Prematurely Ended) PT (Ongoing) GR (Trial now transitioned) BE (Trial now transitioned) SK (Trial now transitioned) BG (Trial now transitioned) LV (Completed) EE (Ongoing) IT (Ongoing) PL (Completed) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002632-24 | Sponsor Protocol Number: P160915 | Start Date*: 2018-11-13 |
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
Full Title: Therapeutic plasma exchange, rituximab and intravenous immunoglobulins (IVIg) for severe acute exacerbation of idiopathic pulmonary fibrosis admitted in ICU: an open, randomized, controlled trial | ||
Medical condition: severe acute exacerbation of idiopathic pulmonary fibrosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024409-11 | Sponsor Protocol Number: LSC-001 | Start Date*: 2011-08-11 | |||||||||||
Sponsor Name:Scottish National Blood Transfusion Service [...] | |||||||||||||
Full Title: Pilot Clinical Assessment of Ex Vivo Expanded Corneal Limbal Stem Cell Transplantation in Patients with Severe Ocular Surface Disease (OSD) Arising from Limbal Stem Cell Deficiency | |||||||||||||
Medical condition: Severe Ocular Surface Disease (OSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002339-23 | Sponsor Protocol Number: MydriasisbeiMydrane | Start Date*: 2019-10-24 |
Sponsor Name:Medical University Graz, Department of Ophtalmology | ||
Full Title: Prospective intraindividual comparison of the mydriasis of a standardized intracameral anaesthetics with the topical preoperative drop application in the uncomplicated cataract surgery | ||
Medical condition: patients who need a cataract surgery in both eyes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002119-23 | Sponsor Protocol Number: IEO1253 | Start Date*: 2020-11-16 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: COVitaminD Trial: prevention of complications from COVID-19 in cancer patients under active treatment | |||||||||||||
Medical condition: Oncological patients in active oncological treatment diagnosed with Covid-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004782-24 | Sponsor Protocol Number: PRM-151-202 | Start Date*: 2016-03-01 | |||||||||||
Sponsor Name:Promedior, Inc. | |||||||||||||
Full Title: A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) | |||||||||||||
Medical condition: Idiopathic Pulmonary Fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) ES (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000586-26 | Sponsor Protocol Number: TIME3UK | Start Date*: 2009-03-20 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Adjuvant Urokinase in the Treatment of Malignant Pleural Effusion: The Third Therapeutic Intervention in Maligant Effusion Trial (TIME3-UK). A Randomised Controlled Trial to evaluate whether use of... | |||||||||||||
Medical condition: Patients with malignant pleural effusions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003524-11 | Sponsor Protocol Number: CIG025A2426 | Start Date*: 2006-09-19 | |||||||||||
Sponsor Name:University Hospital Gent | |||||||||||||
Full Title: Clinical and biological effects of Anti-IgE (Omalizumab) in patients with bilateral nasal polyposis and asthma | |||||||||||||
Medical condition: patients with nasal polyps and comorbid asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001720-33 | Sponsor Protocol Number: CSA_2020 | Start Date*: 2020-09-08 | |||||||||||
Sponsor Name:UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA | |||||||||||||
Full Title: Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in Post Surgical Ocular Surface System Failure Within The Age | |||||||||||||
Medical condition: High-risk patients, i.e. elder patients, who show dry eye syndrome after insult. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001790-16 | Sponsor Protocol Number: LSC2-II-01 | Start Date*: 2019-01-07 | |||||||||||
Sponsor Name:RHEACELL GmbH & Co. KG | |||||||||||||
Full Title: AN INTERVENTIONAL, OPEN-LABEL, MULTICENTER PHASE I/IIA CLINICAL TRIAL TO INVESTIGATE THE SAFETY AND EFFICACY OF ASCENDING DOSES OF ALLOGENEIC ABCB5-POSITIVE LIMBAL STEM CELLS (LSC2) FOR THE TREATME... | |||||||||||||
Medical condition: Limbal stem cell deficiency (LSCD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.